Fixed dose combination therapy of antioxidants in treatment of idiopathic oligoasthenozoospermia: Results of a randomized, double-blind, placebo-controlled clinical trial

International Journal of Infertility and Fetal Medicine

Volumn 4, Issue 1, 2013, Pages 6-13

  Gopinath, P M ^a   Kalra, Bharti ^b   Saxena, Ajit ^c   Malik, Sonia ^d   Kochhar, Kapil ^e   Kalra, Sanjay ^b   Zaveri, Hemant ^f  

^a Department of Medicine   (India)

^b Bharti Research Institute of Diabetes and Endocrinology   (India)

^c Department of Andrology Menz Health Clinic   (India)

^d Department of Obstetrics and Gynecology   (India)

^e Department of Andrology Men's Health Clinic   (India)

^f GUJARAT UNIVERSITY   (India)

Author keywords

Asthenozoospermia; L carnitine; Lycopene; Oligospermia; Ubiquinone (coenzyme Q10); Zinc

Indexed keywords

CARNITINE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; LYCOPENE; PLACEBO; PROLACTIN; SPERM ANTIBODY; TESTOSTERONE; UBIDECARENONE; ZINC;

ADULT; ARTICLE; ASTHENOSPERMIA; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOUBLE BLIND PROCEDURE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYSTEROSALPINGOGRAPHY; IDIOPATHIC OLIGOASTHENOZOOSPERMIA; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MULTICENTER STUDY; OLIGOSPERMIA; OUTCOME ASSESSMENT; PARTHENOGENESIS; PREGNANCY RATE; PROSTATE DISEASE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEMEN ANALYSIS; SEMINAL VESICLE; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TESTIS WEIGHT; VARICOCELE;

EID: 84901003504     PISSN: 22293817     EISSN: 22293833     Source Type: Journal    
DOI: 10.5005/jp-journals-10016-1053     Document Type: Article

References (51)

1. Myrskylä M, Kohler HP, Billari FC. Advances in development reverse fertility declines. Nature 2009;460:741-43.
2. Lutz W. Fertility rates and future population trends: Will Europe's birth rate recover or continue to decline? Int J Androl 2006;29:25-33.
3. Sharlip I, Jarow J, Belker A, Lipshultz L, Sigman M, Thomas A, et al. Best practice policies for male infertility. Fertil Steril 2002;77:873-82.
4. Thonneau P, Marchand S, Tallec A, Ferial ML, Ducot B, Lansac J, et al. Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod 1991;6:811-16.
5. Bunge RG, Keettel WC, Sherman JK. Clinical use of frozen semen; report of four cases. Fertil Steril 1954;5(6):520-29.
6. Dohle GR, Jungwirth A, Colpi G, Giwercman A, Diemer T, Hargreave TB. European Association of Urology. Guidelines on male infertility. Accessed on: May 29, 2012. Available from: http://www.uroweb.org/fileadmin/user_upload/Guidelines/ 13%20Male%20Infertility.pdf
7. Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation and human sperm function. Biol Reprod 1989;40:183-97.
8. Rao B, Soufir JC, Martin M, David G. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Res 1989;24:127-34.
9. Karlsson J. Heart and skeletal muscle ubiquinone or CoQ10 as protective agent against radical formation in man. Adv Myochem 1987;1:305-08.
10. Ernster L, Forsmark-Andree P. Ubiquinol: An endogenous antioxidant in aerobic organisms. Clin Invest 1993;71:60-65.
11. Kalen A, Appelkvist EL, Chojnaki T, Dallner G. Nonaprenyl-4-hydroxibenzoate transferase, an enzyme involved in ubiquinone biosynthesis in endoplasmic reticulum-Golgi system. J Biol Chem 1990;25:1158-64.
12. Mancini A, De Marinis L, Oradei A, Hallgass E, Conte G, Pozza D, et al. Coenzyme Q10 concentration in normal and pathological human seminal fluid. J Androl 1994;15:591-94.
13. Alleva R, Tomassetti M, Battino M, Curatola G, Littarru G, Folkers K. Role of CoQ10 in preventing peroxidation of LDL subfraction. Proc Natl Acad Sci USA 1995;92:9388-91.
14. Mancini A, Conte G, Milardi D, De Marinis L, Littarru G. Relationship between sperm cell ubiquinone and seminal parameters in subjects with and without varicocele. Andrologia 1998;30:1-4.
15. Balercia G, Arnaldi G, Fazioli F, Serresi M, Alleva R, Mancini A, et al. Coenzyme Q10 levels in idiopathic and varicoceleassociated asthenozoospermia. Andrologia 2002;34:107-11.
16. Balercia G, Mantero F, Armeni T, Principato G, Regoli F. Oxyradical scavenging capacity toward different reactive species in seminal plasma and sperm cells. A possible influence on kinetic parameters. Clin Chem Lab Med 2003;41:13-19.
17. Mancini A, De Marinis L, Littarru GP, Balercia G. An update of coenzyme Q10 implications in male infertility: Biochemical and therapeutic aspects. Biofactors 2005;25:165-74.
18. Moradi M, Moradi A, Alemi M, Ahmadnia H, Abdi H, Ahmadi A, et al. Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility. Urol J 2010;7:188-93.
19. Adel RA, Abd-Allah ARA, Helal GK, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, et al. Pro-inflammatory and oxidative stress pathways which compromise sperm motility and survival may be altered by L-carnitine. Oxid Med Cell Long 2009;2:73-81.
20. Ahmed SD, Karira KA, Jagdesh, Ahsan S. Role of L-carnitine in male infertility. J Pak Med Assoc 2011;61(8):732-36.
21. Wang Y, Aggrawal A, et al. Importance of reactive oxygen species in the peritoneal fluid of women with endometriosis or idiopathic infertility. Fertil Steril 1997;68:826-30.
22. Di Mascio P, Kaiser S. Sies H. Lycopene as the most efficient biological cartenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-38.
23. Colagar AH, Marzony ET, Chaichi MJ. Zinc levels in seminal plasma are associated with sperm quality in fertile and infertile men. Nutr Res 2009;29(2):82-88.
24. Balercia G, Buldreghini E, Vignini A, Tiano L, Paggi F, Amoroso S, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: A placebo-controlled, double-blind randomized trial. Fertil Steril 2009;91(5):1785-92.
25. Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol 2009;182(1):237-48.
26. Tang KF, Xing Y, Wu CY, Liu RZ, Wang XY, Xing JP. Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia. Zhonghua Nan Ke Xue 2011;17(7):615-18.
27. Nadjarzadeh A, Sadeghi MR, Amirjannati N, Vafa MR, Motevalian SA, Gohari MR, et al. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenozoospermia: A randomized double-blind, placebo controlled trial. J Endocrinol Invest 2011;34(8):e224-28.
28. Costa M, Canale D, Filicori M, D'lddio S, Lenzi A. L-carnitine in idiopathic asthenozoospermia: A multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia 1994; 26(3):155-59.
29. Lenzi A, Lombardo F, Sgrò P, Salacone P, Caponecchia L, Dondero F, et al. Use of carnitine therapy in selected cases of male factor infertility: A double-blind crossover trial. Fertil Steril 2003;79(2):292-300.
30. Sigman M, Glass S, Campagnone J, Pryor JL. Carnitine for the treatment of idiopathic asthenospermia: A randomized, doubleblind, placebo-controlled trial. Fertil Steril 2006;85(5):1409-14.
31. Gupta NP, Kumar R. Lycopene therapy in idiopathic male infertility-a preliminary report. Int Urol Nephrol 2002;34(3): 369-72.
32. Goyal A, Chopra M, Lwaleed BA, Birch B, Cooper AJ. The effects of dietary lycopene supplementation on human seminal plasma. BJU Int 2007;99(6):1456-60.
33. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP. Effects of folic acid and zinc sulfate on male factor subfertility: A double-blind, randomized, placebo-controlled trial. Fertil Steril 2002;77(3):491-98.
34. Ebisch IM, Pierik FH, DE Jong FH, Thomas CM, Steegers-Theunissen RP. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl 2006;29(2):339-45.
35. World Health Organization. Laboratory manual for examination of semen and semen-cervical mucus interaction (4th ed). New York: Cambridge University Press 1999;60-63 (Appendix IA and IB).
36. WHO laboratory manual for the examination and processing of human semen (5th ed) (page no. 238-41) (Appendix I). WHO Library Cataloguing 0020. http://whqlibdoc.who.int/ publications/2010/9789241547789_eng.pdf
37. Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil 1987;81:459-69.
38. Suleiman SA, Ali ME, Zaki ZM, El-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: Protective role of vitamin E. J Androl 1996;17:530-37.
39. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction 2001;122:497-506.
40. Aitken RJ, Baker MA. Reactive oxygen species generation by human spermatozoa: A continuing enigma. Int J Androl 2002;25: 191-94.
41. Balercia G, Moretti S, Vignini A, Magagnini M, Mantero F, Boscaro M, et al. Role of nitric oxide concentration on human sperm motility. J Androl 2004;25:245-49.
42. Sekine K, Ota N, Nishii M, Uetake T, Shimadzu M. Estimation of plasma and saliva levels of coenzyme Q10 and influence of oral supplementation. Biofactors 2005;25:205-11.
43. Lewis S, Boyle P, McKinney MB, Young I, Thompson W. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril 1995;64:868-70.
44. Rhemrev JP, Van Overveld FW, Haenen GR, Teerlink T, Bast A, Vermeiden JP. Quantification of the nonenzymatic fast and slow TRAP in a postaddition assay in human seminal plasma and the antioxidant contribution of various seminal compounds. J Androl 2000;21:913-20.
45. Moncada ML, Vicari E, Cimino C, Calogero AE, Mongio A, D'Agata R. Effect of acetylcarnitine treatment in oligoasthenospermic patients. Acta Eur Fertil 1992;23:221-24.
46. Sikka SC, Rajasekaran M, Hellstrom WJG. Role of oxidative stress and antioxidant in male infertility. J Androl 1995;16:464-68.
47. Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenozoospermia: Clinical results. Drugs Exp Clin Res 1995;21:157-59.
48. Ford WCL, Whittington K. Antioxidant treatment for male subfertility: A promise that remains unfulfilled. Hum Reprod 1998;13:1416-19.
49. Geva E, Lessing JB, Lerner-Geva L, Amit A. Free radicals, antioxidants and human spermatozoa: Clinical implications. Hum Reprod 1998;13:1415-24.
50. Tarin JJ, Brines J, Cano A. Antioxidants may protect against infertility. Hum Reprod 1998;13:1415-16.
51. Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2011;19(1):CD007411.